137 related articles for article (PubMed ID: 2551533)
1. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage.
Kishimoto C; Abelmann WH
Circ Res; 1989 Oct; 65(4):934-45. PubMed ID: 2551533
[TBL] [Abstract][Full Text] [Related]
2. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.
Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S
Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699
[TBL] [Abstract][Full Text] [Related]
3. Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood.
Kishimoto C; Misaki T; Crumpacker CS; Abelmann WH
Circulation; 1988 Mar; 77(3):645-53. PubMed ID: 2830046
[TBL] [Abstract][Full Text] [Related]
4. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
Takada H; Kishimoto C; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Heart Vessels; 1993; 8(2):59-66. PubMed ID: 8390975
[TBL] [Abstract][Full Text] [Related]
5. Immunologic identification of lymphocyte subsets in experimental murine myocarditis with encephalomyocarditis virus. Different kinetics of lymphocyte subsets between the heart and the peripheral blood, and significance of Thy 1.2+ (pan T) and Lyt 1+, 23+ (immature T) subsets in the development of myocarditis.
Kishimoto C; Kuribayashi K; Fukuma K; Masuda T; Tomioka N; Abelmann WH; Kawai C
Circ Res; 1987 Nov; 61(5):715-25. PubMed ID: 2889539
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
Kishimoto C; Thorp KA; Abelmann WH
Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody therapy for prevention of acute coxsackievirus B3 myocarditis in mice.
Kishimoto C; Abelmann WH
Circulation; 1989 Jun; 79(6):1300-8. PubMed ID: 2541943
[TBL] [Abstract][Full Text] [Related]
9. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
[TBL] [Abstract][Full Text] [Related]
10. Modification of exercise-aggravated coxsackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model.
Cabinian AE; Kiel RJ; Smith F; Ho KL; Khatib R; Reyes MP
J Lab Clin Med; 1990 Apr; 115(4):454-62. PubMed ID: 2157783
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets.
Kishimoto C; Crumpacker CS; Abelmann WH
J Am Coll Cardiol; 1988 Nov; 12(5):1334-41. PubMed ID: 2844874
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis.
Kishimoto C; Kuroki Y; Kurokawa M; Ohiai H
Basic Res Cardiol; 1997 Dec; 92(6):402-9. PubMed ID: 9464864
[TBL] [Abstract][Full Text] [Related]
13. Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in mice.
Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
Heart Vessels; 1997; 12(5):221-8. PubMed ID: 9846807
[TBL] [Abstract][Full Text] [Related]
14. Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice.
Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1992 Oct; 26(10):956-61. PubMed ID: 1336713
[TBL] [Abstract][Full Text] [Related]
15. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
Kishimoto C; Abelmann WH
Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune cardiocyte injury in viral myocarditis of mice and patients.
Deguchi H; Kitaura Y; Hayashi T; Kotaka M; Kawamura K
Jpn Circ J; 1989 Jan; 53(1):61-77. PubMed ID: 2541265
[TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.
Estrin M; Huber SA
Am J Pathol; 1987 May; 127(2):335-41. PubMed ID: 3034068
[TBL] [Abstract][Full Text] [Related]
18. Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice.
Hiraoka Y; Kishimoto C; Takada H; Kurokawa M; Ochiai H; Shiraki K; Sasayama S
Cardiovasc Res; 1993 Jun; 27(6):957-61. PubMed ID: 8221785
[TBL] [Abstract][Full Text] [Related]
19. Changed distribution and immune effects of nickel augment viral-induced inflammatory heart lesions in mice.
Ilbäck NG; Fohlman J; Friman G
Toxicology; 1994 Jul; 91(2):203-19. PubMed ID: 8059443
[TBL] [Abstract][Full Text] [Related]
20. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects.
Takada H; Kishimoto C; Hiraoka Y
Circulation; 1995 Sep; 92(6):1604-11. PubMed ID: 7664447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
